| IE方案治疗难治性和复发性白血病13例疗效观察 |
| |
| 引用本文： | 王梦昌,韩丽,李满祥.IE方案治疗难治性和复发性白血病13例疗效观察[J].西安交通大学学报(医学版),2000,21(4):371-372. |
| |
| 作者姓名： | 王梦昌 韩丽 李满祥 |
| |
| 作者单位： | 西安交通大学第一医院血液科，西安 710061 |
| |
| 摘 要： | 探讨以口服去甲氧柔红霉素为主联合化疗方案治疗难治性和复发性白血病的疗效。方法 对难治性及复发性白血病均采用 IE(去甲氧柔红霉素 ,足叶乙甙 )方案诱导化疗 ,完全缓解后再用其他方案巩固强化。结果 完全缓解率 46.1 5% ,部分缓解率 2 3% ,总缓解率69.1 5%。结论 去甲氧柔红霉素口服吸收良好 ,对难治性及复发性白血病有较好疗效 ,值得推广应用。
|
| 关 键 词： | 去甲氧柔红霉素 足叶乙甙 白血病 难治性 |
| 文章编号： | 0258-0659(2000)04-0371-02 |
| 修稿时间： | 1999年11月19 |
The observation of treatment effect of thirteen refractory leukemia and relapse leukemia with idarubicin and etoposide |
| |
| Abstract: | Objective To explore the effect of oral intake idarubicin(IDA) in combined chemotherapy for refractory leukemia and relapse leukemia. Methods Refractory leukemia and relapse leukemia were induced by idarubicin,etoposide(IE),then it was followed by consolidated and intensified therapy with other combined chemotherapy after complete remassion. Results Results indicated that complete remassion rate, partial remassion rate and total remassion rate was 46.15%, 23% and 69.15% respectively.Conclusion Oral intake IDA had satisffied absorbtion rate and theraputic effect in treatment of leukemia, which shows an application value in clinic. |
| |
| Keywords: | idarubicin etoposide leukemia refractory |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
